The U.S. Food and Drug Administration approved Opiant Pharmaceuticals' Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older.
Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose.
Indivior is a pharmaceutical company. | May 23, 2023
Indivior PLC (LON:INDV – Get Rating) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 1,455.32 ($18.23) and traded as high as GBX 1,493 ($18.70). Indivior shares last traded at GBX 1,474 ($18.46), with a volume of 265,962 shares traded. Analyst […]
Indivior PLC (OTCMKTS:INVVY – Get Rating)’s share price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $23.43 and traded as high as $25.69. Indivior shares last traded at $23.00, with a volume of 2,886 shares. Indivior Price Performance The firm has a […]
Indivior PLC (LON:INDV – Get Rating) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,663.21 ($20.78) and traded as low as GBX 1,566 ($19.57). Indivior shares last traded at GBX 1,585 ($19.80), with a volume of 232,981 shares traded. Analyst Ratings Changes […]